FCA still yet to fully investigate vast majority of Covid-related whistleblowing reports

whistle

The Financial Conduct Authority has yet to close the majority of Covid-related whistleblowing reports received in the past 18 months, according to a freedom of information request made by Post.

Whistleblowers continue to emerge with reports relating to Covid even in the aftermath of the pandemic period. Reports relate to firms in all areas of financial services, including general insurance

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: http://subscriptions.postonline.co.uk/subscribe

You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Post? View our subscription options

Q&A: Chaz Perera, Roots Automation

Chaz Perera, CEO and co-founder of Roots Automation, tells Insurance Post about the firm’s generative artificial intelligence model specially trained for insurance InsurGPT and the challenges in the industry this technology is primed to solve.

FCA scraps name and shame proposals

The Financial Conduct Authority has scrapped plans to name and shame firms it is investigating and revealed it has “no plans” to progress its diversity and inclusion proposals.

Is time ticking on leasehold altogether?

News Editor’s View: Scott McGee asks if the insurance industry's headache of having to justify the fees charged to flat owners for arranging cover is about to be replaced by the pain that will come with leasehold status being ditched for commonhold ownership.

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here